Medical specialists from United Kingdom tagged as investigators in clinical trials studying Monoclonal Mast Cell Activation Syndrome
Total 2 results
-
Bethan Psaila, MD, PhDSeen in:
- Oxford, Cancer and Haematology Centre
Trials:- NCT04910685 (Principal Investigator)
-
Steven Knapper, MDSeen in:
- Wales, Cardiff, University Hospital of Wales
Trials:- NCT04603495 (Principal Investigator)
- NCT04910685 (Principal Investigator)
Clinical Trials on Monoclonal Mast Cell Activation Syndrome
-
Blueprint Medicines CorporationRecruitingIndolent Systemic Mastocytosis | Monoclonal Mast Cell Activation SyndromeUnited States, Spain, Australia, France, Netherlands, Switzerland, Norway, United Kingdom, Austria, Belgium, Germany, Italy, Portugal
-
FSD Pharma, Inc.TerminatedMast Cell Activation Syndrome | Mast Cell Activation Disorder IdiopathicCanada, United States
-
Blueprint Medicines CorporationCompletedSystemic Mast Cell Activation | KIT D816V MutationUnited States, France, United Kingdom, Italy, Germany, Belgium, Spain, Switzerland
-
National Institute of Allergy and Infectious Diseases...RecruitingMastocytosis | Bone Marrow | Monoclonal | TryptaseUnited States
-
Poitiers University HospitalCompletedMast Cell Activation Syndrome | Urticaria Pigmentosa | Mast Cell Activation Disease | Mast Cell DiseaseFrance
-
AB ScienceRecruitingMast Cell Activation SyndromeFrance, United States
-
Blueprint Medicines CorporationActive, not recruitingMast Cell Leukemia | Aggressive Systemic Mastocytosis | Advanced Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematologic NeoplasmUnited States, Canada, United Kingdom, France, Netherlands, Italy, Spain, Austria, Denmark, Germany, Norway, Poland
-
University Hospital, ToulouseNot yet recruiting
-
Blueprint Medicines CorporationActive, not recruitingIndolent Systemic MastocytosisCanada, United States, Spain, United Kingdom, Germany, Belgium, Switzerland, Italy, Netherlands, Denmark, France, Norway, Sweden